Streetbeat News

Analyst Ratings

ATAI

HC Wainwright & Co. has reiterated its Buy rating on ATAI Life Sciences (NASDAQ:ATAI) and maintained a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:29 pm

MGNX

MHUA

VST

Market-Moving News for July 31st: Meihua International's NT-2000 system supported a 5G remote robot-assisted lobectomy, boosting shares by 121%. MacroGenics shares fell 28% after announcing clinical data presentation and multiple analyst downgrades. Vistra shares rose 17% following the extension approval for Comanche Peak Nuclear Power Plant.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:28 pm

AWR

ECL

GPS

MMM

PYPL

Top Wall Street analysts have upgraded their ratings for 3M Company, American States Water Company, Ecolab Inc., The Gap, Inc., and PayPal Holdings, Inc. These upgrades have led to varying impacts on the stock prices of these companies.

Portfolio Pulse from Avi Kapoor

July 31, 2024 | 12:27 pm

NARI

Baird analyst David Rescott maintains an Outperform rating on Inari Medical (NASDAQ:NARI) but lowers the price target from $65 to $63.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:26 pm

LULU

Baird analyst Mark Altschwager maintains an Outperform rating on Lululemon Athletica (NASDAQ:LULU) but lowers the price target from $470 to $350.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:24 pm

KRG

Baird analyst Wesley Golladay maintains a Neutral rating on Kite Realty Group Trust (NYSE:KRG) and raises the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:23 pm

AKA

Small Cap Consumer Research analyst Eric Beder has reiterated a Buy rating on a.k.a. Brands Holding (NYSE:AKA) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:22 pm

IT

Baird analyst Jeffrey Meuler maintains an Outperform rating on Gartner (NYSE:IT) and raises the price target from $517 to $565.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:22 pm

INFA

Baird analyst William Power maintains an Outperform rating on Informatica (NYSE:INFA) but lowers the price target from $43 to $35.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:20 pm

SGMO

HC Wainwright & Co. has reiterated its Buy rating on Sangamo Therapeutics (NASDAQ:SGMO) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 12:20 pm